Stay updated on Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.

Latest updates to the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedIntroduced a centralized Locations section listing participating sites by region (including US states and Flemish Brabant) and removed the separate per-location 'Locations' subpages in favor of the consolidated section; Revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check52 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.0%

- Check59 days agoChange DetectedRemoved a generic government funding status notice from the page. The study details, contacts, and locations remain unchanged.SummaryDifference0.3%

- Check74 days agoChange DetectedThe record for NCT02988817 now includes posted results, with Results First Submitted on 2022-11-07 and Results First Posted on 2023-01-05, and a last update on 2023-08-01. The page’s results section updates the outcome data and status history.SummaryDifference0.3%

- Check102 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

Stay in the know with updates to Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.